Skip to main content
PGNY logo

PGNY · Progyny, Inc. · Investor Relations

Track PGNY — free
Market Cap
$2.66B
Shares
73.65M
Volume · Nov 18 913.51K Avg daily vol (3M) 1.1M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-11-04 Progyny, Inc. Announces Third Quarter 2026 Results
2026-10-28 New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits

Research presented at ASRM 2026 Scientific Congress & Expo highlights the importance of early engagement and personalized support in helping patients navigate fertility care NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family

2026-10-26 New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model

More than 70% of members in the study reported symptom improvement, with the greatest gains among those receiving both personalized coaching and menopause-trained provider care NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family

2026-10-21 Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended September 30, 2026, after the close of the market on Wednesday, November 4, 2026.

2026-10-15 Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting

NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, announced today that it will present new research evaluating real-world outcomes from its Menopause and Midlife program and exhibit at The Menopause Society

2026-10-07 Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics

Expecting 1.2 Million New Covered Lives from Commitments to Date and Anticipated Remaining Decisions Reflects How Employers are Increasingly Turning to Solutions with a Proven Track Record of Delivering Savings, Total Cost Management and ROI Progyny’s Solutions Creating Compelling Opportunities

2026-09-03 Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its Chief Financial Officer Mark Livingston will present at the Wells Fargo 21 st Annual Healthcare Conference in Boston, MA on Tuesday,

2026-08-07 Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 3:30

2026-08-06 Progyny, Inc. Announces Second Quarter 2026 Results

Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDA Robust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building Solutions Value Returned to Shareholders Through the Repurchase of Over 2 Million Shares Under Current Authorization NEW YORK,

2026-07-23 Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended June 30, 2026 after the close of the market on Thursday, August 6, 2026.

2026-05-28 New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- A new survey from Progyny (Nasdaq: PGNY), a global leader in women’s health and family building solutions, found that people

2026-05-26 Progyny, Inc. Announces Share Repurchase Program

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock.

2026-05-11 Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the

2026-05-07 Progyny, Inc. Announces First Quarter 2026 Results

Reports Record First Quarter Revenue of $328.5 Million Early Selling Season Activity Reflects Robust Demand for Women's Health and Family Building Solutions Returned Value to Shareholders Through Repurchase of 8.8 Million Shares to Date Since November NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) --

2026-04-23 Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report

NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended March 31, 2026, after the close of the market on Thursday, May 7, 2026.

2026-04-16 Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan

First-of-its-kind plan expands access to comprehensive, outcomes-based family building and women’s health care with predictable costs for small U.S. employers NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions,

2026-04-01 Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care

Throughout 2026, in partnership with members, providers, and employers, Progyny will highlight a decade of innovation, expanded access, and industry-leading outcomes. NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Over the past ten years, millions of individuals and families have gained access to

2026-03-06 Progyny, Inc. Executives to Participate in Upcoming Investor Conferences

NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that several members of its leadership team will participate in upcoming investor conferences in March, including the Leerink Partners Global

2026-02-26 Progyny, Inc. Announces Fourth Quarter 2025 Results

Reports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full Year Generated Record $210.2 Million in Full Year Operating Cash Flow Returned Value to Shareholders Through Repurchase of Approximately 6.5 Million Shares To Date Under Recent Authorization Issues

2026-02-12 Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025, after the close of the market on Thursday, February 26, 2026.

Past events

Date Event Type
2026-11-04 Progyny 3rd Quarter 2026 Earnings Conference Call Earnings call
2026-09-08 Wells Fargo 21st Annual Healthcare Conference Conference
2026-08-11 Canaccord Genuity 46th Annual Growth Conference Conference
2026-08-06 Progyny 2nd Quarter 2026 Earnings Conference Call Earnings call
2026-05-21 Progyny 2026 Virtual Annual Meeting Shareholder meeting
2026-05-12 BofA Securities 2026 Health Care Conference Conference
2026-05-07 Progyny 1st Quarter 2026 Earnings Conference Call Earnings call
2026-03-17 KBCM Healthcare Forum Webcast
2026-03-11 Barclays 28th Annual Global Healthcare Conference Conference
2026-03-10 Leerink Partners 2026 Global Healthcare Conference Conference
2026-02-26 Progyny 4th Quarter 2025 Earnings Conference Call Earnings call
2026-01-13 44th Annual JP Morgan Healthcare Conference Conference
2025-11-18 Jefferies Global Healthcare Conference in London Conference
2025-11-06 Progyny 3rd Quarter 2025 Earnings Conference Call Earnings call
2025-08-07 Progyny 2nd Quarter 2025 Earnings Conference Call Earnings call
2025-05-22 Progyny 2025 Virtual Annual Meeting Event
2025-05-14 BofA Securities 2025 Health Care Conference Conference
2025-05-08 Progyny 1st Quarter 2025 Earnings Conference Call Earnings call
2025-03-19 KeyBanc Capital Markets Healthcare Forum Event
2025-03-10 Leerink Partners Global Healthcare Conference Conference
2025-02-27 Progyny 4th Quarter 2024 Earnings Conference Call Earnings call
2025-01-14 JP Morgan Healthcare Conference Conference
2024-11-19 Jefferies London Healthcare Conference Conference
2024-11-12 Progyny 3rd Quarter 2024 Earnings Conference Call Earnings call
2024-08-12 2024 Inaugural Investor Day Presentation

Source: https://investors.progyny.com/

Key facts CIK 1551306 CUSIP 74340E103 13F (30d) 310 filings 287 filers Visit website Investor relations